---
title: "Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy"
description: "The goal of this clinical research study is to learn if the addition of sunitinib malate (SU011248) to hormone based castration is an effective treatment f"
url: "https://www.clareohealth.com/clinical-trials/NCT00329043"
---

The goal of this clinical research study is to learn if the addition of sunitinib malate (SU011248) to hormone based castration is an effective treatment for shrinking or controlling the tumor before having the prostate removed.

## Key Facts

**ID:** NCT00329043
**Status:** ACTIVE_NOT_RECRUITING
**Phase:** PHASE2
**Type:** INTERVENTIONAL
**Enrollment:** 64
**Sponsor:** M.D. Anderson Cancer Center

## About This Study

This clinical trial is testing sunitinib malate, a new treatment, combined with hormonal therapy to see if it can help shrink prostate tumors before surgery in men with high-risk localized prostate cancer. The goal is to determine if this combination is effective in preparing patients for prostate removal surgery.

## Conditions

- Prostate Cancer

## Interventions

**DRUG: LHRH Agonist**
Intramuscular injection either monthly for 3 months or in a single 3-month dose.

**DRUG: Sunitinib Malate**
25 to 37.5 mg/day once daily for 30 days (= 1 cycle), up to 3 cycles.

**PROCEDURE: Radical Prostatectomy**
Radical prostatectomy after completion of Sunitinib and LHRH agonist.

## Eligibility

Inclusion Criteria: 1. Patients with histologically confirmed adenocarcinoma of the prostate that in the opinion of the surgeon is resectable.

## Who Can Participate

**Sex:** MALE

**Accepts healthy volunteers:** No

## Study Locations

- University of Texas MD Anderson Cancer Center, Houston, Texas, United States

## Contact Information

## Important Dates

**Study start:** May 15, 2006

**Completion date:** December 31, 2027

**Last updated:** June 12, 2026

## Collaborators

- Pfizer

## Consider Discussing with Your Care Team

### Worth Discussing If

- You have high-risk localized prostate cancer and are planning to have surgery.
- You are interested in new treatment options that may help shrink your tumor before surgery.
- You want to explore clinical trials as part of your treatment plan.

### Questions to Ask

- What are the potential benefits of participating in this trial?
- What side effects should I expect from sunitinib malate and hormonal therapy?
- How will this treatment affect my surgery and recovery?
- What kind of monitoring will I receive during the trial?
- Are there any risks I should be aware of with this combination treatment?
- How does this trial compare to standard treatment options available for my condition?

[View on ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00329043)
